QT
TARS icon

Quantbot Technologies’s Tarsus Pharmaceuticals TARS Stock Holding History

Quantbot Technologies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Sell
4,579
-8,942
-66% -$571K 0.01% 1132
2026
Q1 		$948K Buy
13,521
+6,419
+90% +$449K 0.04% 614
2025
Q4 		$582K Buy
7,102
+2,369
+50% +$177K 0.02% 880
2025
Q3 		$281K Sell
4,733
-35,606
-88% -$1.75M 0.01% 1195
2025
Q2 		$1.63M Buy
40,339
+24,319
+152% +$1.09M 0.04% 600
2025
Q1 		$823K Buy
+16,020
New +$792K 0.03% 745
2024
Q3 		– Sell
-10,685
Closed -$290K – 1819
2024
Q2 		$290K Sell
10,685
-581
-5% -$19.5K 0.01% 878
2024
Q1 		$410K Buy
+11,266
New +$331K 0.02% 804

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quantbot Technologies's TARS Position: Q2 2026 in Review

Quantbot Technologies reduced its Tarsus Pharmaceuticals (TARS) stake by 66% in Q2 2026, selling an estimated $571K and leaving 4,579 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #1132.

Quantbot Technologies first reported a position in TARS in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Quantbot Technologies held 4,579 shares of Tarsus Pharmaceuticals worth $288K as of Q2 2026.
  • Quantbot Technologies sold 8,942 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $571K.
  • Tarsus Pharmaceuticals made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1132 holding.
  • Quantbot Technologies first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Quantbot Technologies's Tarsus Pharmaceuticals position peaked at $1.63M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.